P3 Health Partners stock faces November 9 results date

P3 Health Partners has set November 9, 2026, as the release date for its third-quarter results, putting the company’s operating performance and outlook back in focus. The announcement was published by P3 Health Partners on October 22.

Management plans to hold a conference call at 4:30 p.m. Eastern Time on November 9, or 1:30 p.m. Pacific Time. The call will address the third-quarter financial results, while the earnings release is scheduled to be posted on the company’s investor-relations website before the event.

Results Date Gives Investors A Near-Term Catalyst

The scheduled release gives investors a defined date for assessing revenue, medical-cost trends, cash use and the company’s progress in population health management. The call may also clarify how management views the balance between growth, care delivery and the path toward more sustainable earnings.

P3 Health Partners stock traded at 4.00 US dollars on Nasdaq at 4:00 p.m. Eastern Time on Monday, November 2, 2026. The quote was the latest available market price for PIII and is presented without a Xetra comparison.

P3 Health Partners describes itself as a patient-centered, physician-led population health management company. It supports primary-care providers through value-based care coordination and administrative services, and the company says its local teams manage patients across 26 counties in five states.

P3 operates in the United States and says its network includes more than 2,100 affiliated primary-care providers. Its model centers on partnerships with local providers, care navigation and coordination rather than a conventional product-led healthcare offering.

Healthcare investors can follow broader developments through current market reports.

More company updates are available in more news and analyses on P3 Health Partners stock.